🇺🇸 FDA
Patent

US 11753444

Modulation of structured polypeptide specificity

granted A61PA61P11/02A61P17/00

Quick answer

US patent 11753444 (Modulation of structured polypeptide specificity) held by BicycleRD Limited expires Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BicycleRD Limited
Grant date
Tue Sep 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61P, A61P11/02, A61P17/00, A61P17/04, A61P27/02